See more : Aquarius Engines (A.M) Ltd. (AQUEF) Income Statement Analysis – Financial Results
Complete financial analysis of Astrotech Corporation (ASTC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Astrotech Corporation, a leading company in the Aerospace & Defense industry within the Industrials sector.
You may be interested
- Saudi Re for Cooperative Reinsurance Company (8200.SR) Income Statement Analysis – Financial Results
- Blue Room Acquisition Corp. Unit (IBLUU) Income Statement Analysis – Financial Results
- Raen S.A. (RAE.WA) Income Statement Analysis – Financial Results
- HFCL Limited (HFCL.NS) Income Statement Analysis – Financial Results
- Gufic Biosciences Limited (GUFICBIO.NS) Income Statement Analysis – Financial Results
Astrotech Corporation (ASTC)
About Astrotech Corporation
Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.66M | 750.00K | 869.00K | 334.00K | 488.00K | 127.00K | 86.00K | 2.33M | 2.67M | 513.00K | 16.42M | 24.00M | 26.14M | 20.15M | 27.98M | 31.99M | 25.54M | 52.76M | 50.75M | 59.40M | 77.61M | 94.96M | 102.77M | 105.25M | 105.71M | 107.70M | 64.10M | 56.60M | 46.10M | 43.80M |
| Cost of Revenue | 913.00K | 444.00K | 677.00K | 298.00K | 449.00K | 90.00K | 36.00K | 1.29M | 2.33M | 424.00K | 10.71M | 15.68M | 18.79M | 13.67M | 12.86M | 15.72M | 19.54M | 51.03M | 46.86M | 47.16M | 45.68M | 78.79M | 81.77M | 92.24M | 79.18M | 81.80M | 29.20M | 23.90M | 14.80M | 24.23M |
| Gross Profit | 751.00K | 306.00K | 192.00K | 36.00K | 39.00K | 37.00K | 50.00K | 1.04M | 339.00K | 89.00K | 5.72M | 8.31M | 7.35M | 6.48M | 15.12M | 16.26M | 6.00M | 1.73M | 3.89M | 12.24M | 31.93M | 16.17M | 21.01M | 13.01M | 26.53M | 25.90M | 34.90M | 32.70M | 31.30M | 19.57M |
| Gross Profit Ratio | 45.13% | 40.80% | 22.09% | 10.78% | 7.99% | 29.13% | 58.14% | 44.46% | 12.69% | 17.35% | 34.82% | 34.64% | 28.11% | 32.17% | 54.04% | 50.84% | 23.50% | 3.28% | 7.67% | 20.61% | 41.14% | 17.03% | 20.44% | 12.36% | 25.09% | 24.05% | 54.45% | 57.77% | 67.90% | 44.69% |
| Research & Development | 6.79M | 5.59M | 2.78M | 2.69M | 3.44M | 3.58M | 6.07M | 5.59M | 6.47M | 3.23M | 2.51M | 2.08M | 2.57M | 3.83M | 2.80M | 2.33M | 1.38M | 801.00K | 410.00K | 77.00K | 223.00K | 118.00K | 383.00K | 393.00K | 2.44M | 3.60M | 2.60M | 1.30M | 100.00K | 0.00 |
| General & Administrative | 1.36M | 1.46M | 1.50M | 0.00 | 0.00 | 0.00 | 5.63M | 7.51M | 7.71M | 12.97M | 8.89M | 6.79M | 7.07M | 8.40M | 12.17M | 9.76M | 9.15M | 9.88M | 10.67M | 9.38M | 10.91M | 41.17M | 18.74M | 21.80M | 17.83M | 14.60M | 13.70M | 8.60M | 4.60M | 5.06M |
| Selling & Marketing | 5.88M | 4.32M | 4.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 800.00K | 0.00 |
| SG&A | 7.24M | 5.78M | 6.01M | 4.74M | 4.72M | 4.88M | 5.63M | 7.51M | 7.71M | 12.97M | 8.89M | 6.79M | 7.07M | 8.40M | 12.17M | 9.76M | 9.15M | 9.88M | 10.67M | 9.38M | 10.91M | 41.17M | 18.74M | 21.80M | 17.83M | 14.60M | 13.70M | 8.60M | 5.40M | 5.06M |
| Other Expenses | 0.00 | 1.42M | 265.00K | 215.00K | 0.00 | 0.00 | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 213.00K | 3.88M | 0.00 | -7.74M | 10.07M | 50.27M | 770.00K | 0.00 | 8.75M | 7.50M | 5.80M | 10.20M | 6.20M | 0.00 |
| Operating Expenses | 14.03M | 11.37M | 8.79M | 7.43M | 8.15M | 8.45M | 11.69M | 13.10M | 14.18M | 16.20M | 11.40M | 8.87M | 9.64M | 12.24M | 14.97M | 12.09M | 10.74M | 14.56M | 11.08M | 1.72M | 21.21M | 91.55M | 19.89M | 22.19M | 29.02M | 25.70M | 22.10M | 20.10M | 13.90M | 5.06M |
| Cost & Expenses | 14.94M | 11.81M | 9.46M | 7.73M | 8.60M | 8.54M | 11.73M | 14.39M | 16.51M | 16.62M | 22.10M | 24.55M | 28.43M | 25.90M | 27.83M | 27.81M | 30.28M | 65.59M | 57.94M | 48.87M | 66.88M | 170.34M | 101.66M | 114.43M | 108.20M | 107.50M | 51.30M | 44.00M | 28.70M | 29.29M |
| Interest Income | 0.00 | 0.00 | 0.00 | 275.00K | 197.00K | 25.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 114.66K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 265.00K | 235.00K | 197.00K | 0.00 | 0.00 | 0.00 | 0.00 | 224.00K | 0.00 | 164.00K | 1.03M | 279.00K | 459.00K | 622.00K | 427.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 0.00 |
| Depreciation & Amortization | 874.00K | 489.00K | 236.00K | 55.00K | 189.00K | 268.00K | 765.00K | 731.00K | 572.00K | 320.00K | 2.31M | 2.12M | 2.24M | 2.32M | 2.14M | 2.21M | 2.67M | 6.36M | 6.06M | 5.53M | 5.88M | 9.39M | 13.41M | 10.57M | 8.75M | 7.50M | 5.80M | 10.20M | 8.50M | 0.00 |
| EBITDA | -12.41M | -10.69M | -8.36M | -7.31M | -7.58M | -8.15M | -10.88M | -11.33M | -13.43M | -15.79M | -10.18M | 1.56M | -47.00K | -3.44M | 2.29M | 7.05M | -4.73M | -5.71M | -792.00K | 16.05M | 16.61M | -66.00M | 14.53M | 1.40M | 6.26M | 7.70M | 18.60M | 22.80M | 25.80M | 14.51M |
| EBITDA Ratio | -745.55% | -1,474.67% | -989.07% | -2,223.35% | -1,553.48% | -6,627.56% | -10,681.40% | -486.64% | -496.67% | -3,078.17% | -20.50% | 6.48% | -0.18% | -17.07% | 8.18% | 22.03% | 110.96% | -4.91% | -2.22% | 13.99% | 34.38% | -16.56% | 14.89% | 1.33% | 5.92% | 7.15% | 22.93% | 37.10% | 55.97% | 33.13% |
| Operating Income | -13.28M | -11.06M | -8.60M | -7.40M | -8.11M | -8.42M | -13.34M | -12.06M | -13.84M | -16.11M | -5.68M | -559.00K | -2.29M | -5.76M | 153.00K | 4.17M | -4.73M | -12.83M | -7.19M | 10.53M | 10.72M | -75.38M | 1.12M | -9.18M | -2.50M | 200.00K | 12.80M | 12.60M | 17.40M | 14.51M |
| Operating Income Ratio | -798.08% | -1,474.67% | -989.07% | -2,214.67% | -1,662.70% | -6,627.56% | -15,508.14% | -518.04% | -518.08% | -3,140.55% | -34.59% | -2.33% | -8.76% | -28.56% | 0.55% | 13.04% | -18.52% | -24.32% | -14.17% | 17.72% | 13.82% | -79.38% | 1.09% | -8.72% | -2.36% | 0.19% | 19.97% | 22.26% | 37.74% | 33.13% |
| Total Other Income/Expenses | 1.62M | 1.42M | 265.00K | -206.00K | -197.00K | 25.00K | 86.00K | 306.00K | 379.00K | 224.00K | -182.00K | -164.00K | -1.03M | -279.00K | -459.00K | 43.00K | -30.62M | -3.53M | -5.17M | -5.42M | -8.14M | -7.25M | -5.53M | -4.49M | -3.11M | -3.30M | -700.00K | 1.00M | -1.36M | -14.51M |
| Income Before Tax | -11.66M | -9.64M | -8.33M | -7.60M | -8.31M | -8.39M | -13.25M | -11.75M | -13.46M | -15.89M | -5.86M | -723.00K | -3.32M | -6.03M | -306.00K | 4.22M | -35.35M | 16.36M | -12.37M | 5.10M | 2.58M | -82.63M | -4.42M | -13.67M | -5.61M | -3.10M | 12.10M | 13.60M | 16.00M | 0.00 |
| Income Before Tax Ratio | -700.96% | -1,285.60% | -958.57% | -2,276.35% | -1,703.07% | -6,607.87% | -15,408.14% | -504.90% | -503.89% | -3,096.88% | -35.69% | -3.01% | -12.69% | -29.95% | -1.09% | 13.18% | -138.40% | 31.01% | -24.37% | 8.59% | 3.33% | -87.01% | -4.30% | -12.99% | -5.30% | -2.88% | 18.88% | 24.03% | 34.71% | 0.00% |
| Income Tax Expense | 2.00K | -489.00K | -766.00K | 3.00K | 197.00K | -858.00K | 86.00K | 2.00K | -25.00K | -5.94M | 6.00K | -538.00K | 17.00K | -53.00K | 22.00K | -510.00K | 675.00K | -69.00K | 32.00K | -146.00K | 506.00K | -857.00K | -2.05M | -886.00K | -1.76M | -500.00K | 2.50M | 3.00M | 200.00K | -8.64M |
| Net Income | -11.67M | -9.64M | -7.56M | -7.61M | -8.51M | -7.53M | -13.25M | -11.58M | -13.10M | 10.78M | -4.96M | -185.00K | -2.71M | -4.98M | 260.00K | 4.73M | -36.03M | -16.29M | -12.40M | 5.25M | 2.08M | -81.78M | -2.37M | -12.79M | -3.84M | -2.60M | 9.60M | 13.90M | 15.80M | 8.64M |
| Net Income Ratio | -701.08% | -1,285.60% | -870.43% | -2,277.25% | -1,743.44% | -5,932.28% | -15,408.14% | -497.51% | -490.27% | 2,100.97% | -30.20% | -0.77% | -10.38% | -24.73% | 0.93% | 14.77% | -141.04% | -30.88% | -24.43% | 8.84% | 2.67% | -86.11% | -2.30% | -12.15% | -3.64% | -2.41% | 14.98% | 24.56% | 34.27% | 19.72% |
| EPS | -7.12 | -5.95 | -4.76 | -10.38 | -40.22 | -45.75 | -97.89 | -85.09 | -96.34 | 78.00 | -38.18 | -1.50 | -21.95 | -41.94 | 3.00 | 43.50 | -583.97 | -1.89K | -1.46K | 630.00 | 255.00 | -9.98K | -298.79 | -1.68K | -511.51 | -348.71 | 1.29K | 1.86K | 3.56K | 2.55K |
| EPS Diluted | -7.12 | -5.95 | -4.76 | -10.38 | -40.22 | -45.75 | -97.89 | -85.08 | -96.34 | 78.00 | -38.18 | -1.44 | -21.95 | -41.94 | 1.50 | 42.00 | -583.97 | -1.89K | -1.46K | 555.00 | 225.00 | -9.98K | -298.79 | -1.68K | -511.51 | -348.71 | 1.26K | 1.86K | 3.56K | 1.94K |
| Weighted Avg Shares Out | 1.64M | 1.62M | 1.59M | 732.80K | 211.53K | 164.67K | 135.37K | 136.12K | 135.92K | 132.07K | 129.91K | 123.33K | 123.63K | 118.81K | 110.45K | 109.10K | 61.70K | 8.61K | 8.50K | 8.41K | 8.30K | 8.19K | 7.92K | 7.60K | 7.52K | 7.46K | 7.44K | 7.41K | 4.45K | 3.39K |
| Weighted Avg Shares Out (Dil) | 1.64M | 1.62M | 1.59M | 732.80K | 211.53K | 164.67K | 135.37K | 136.13K | 135.92K | 132.07K | 129.91K | 128.85K | 123.63K | 118.81K | 121.89K | 112.69K | 61.70K | 8.61K | 8.50K | 9.46K | 9.43K | 8.19K | 7.92K | 7.60K | 7.52K | 7.46K | 9.71K | 7.44K | 4.45K | 4.49K |
Astrotech Reports First Quarter of Fiscal Year 2025 Financial Results
AUSTIN, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the first quarter of fiscal year 2025, which ended September 30, 2024.
Astrotech Reports Fiscal Year 2024 Financial Results
AUSTIN, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2024.
Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results
AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2024, which ended March 31, 2024.
Astrotech Announces Listing to the GSA as an Approved United States Government Vendor
Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce...
Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference
The TRACER 1000 Narcotic and Explosives Trace Detector is a rugged mass-spectrometer capable of rapid detection of trace levels of narcotic or explosive compounds in seconds. The TRACER 1000 Narcotic and Explosives Trace Detector is a rugged mass-spectrometer capable of...
Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000
The TRACER 1000™ is a mass spectrometry-based trace analyzer; its detection library now includes narcotics such as fentanyl, heroin, and cocaine. The TRACER 1000™ is a mass spectrometry-based trace analyzer; its detection library now includes narcotics such as fentanyl, heroin,...
Astrotech Reports Second Quarter Of Fiscal Year 2024 Financial Results
AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2024, which ended December 31, 2023.
Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary
AUSTIN, Texas, Dec. 12, 2023 (GLOBE NEWSWIRE) -- - via IBN - Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announces formation of a wholly owned subsidiary Pro-Control, Inc. (“Pro-Control”) and has entered into an exclusive license to use the ATi...
Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems
Astrotech's proven AgLAB Maximum Value Process™ delivers 32% average increase in revenue Astrotech's proven AgLAB Maximum Value Process™ delivers 32% average increase in revenue
Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results
AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the first quarter of fiscal year 2024, which ended September 30, 2023.
Source: https://incomestatements.info
Category: Stock Reports